Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SANUWAVE Health, Inc.SNVW · Entity 7321 | Director | September 30, 2026 | October 03, 2026 |
| TELA Bio, Inc.TELA · Entity 7381 | President | February 20, 2026 | February 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SANUWAVE Health, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.71 · Expires 2031-09-30 | Direct | 11,286 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 11,286 · Balance 11,286 F1: Options were fully vested at the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Options were fully vested at the grant date.
TELA Bio, Inc.
Report date February 20, 2026 · Filed February 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 205,125 |
Reported balance
After 2026-02-20 transaction · row 1
1 source rowRow 1 · 2026-02-20 · Grant · Acquired 86,000 · Balance 205,125 F1: These restricted stock units will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.72 · Expires 2036-02-20 | Direct | 127,000 |
Reported balance
After 2026-02-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-20 · Grant · Acquired 127,000 · Balance 127,000 F2: The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2: The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 01:02 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 11,286 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0002012926-26-000011 · form4-10022026_091037.xml · derivative · entry 1 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 Underlying: Common Stock · 11,286 shares Expires 2031-09-30 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:13 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 5,524 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0002012926-26-000008 · form4-07022026_080754.xml · derivative · entry 1 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,524 Underlying: Common Stock · 5,524 shares Expires 2031-06-30 F1 · derivative.exercise_date: Options were vested at the grant date. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:08 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 3,208 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0002012926-26-000006 · form4-04022026_090425.xml · derivative · entry 1 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,208 Underlying: Common Stock · 3,208 shares Expires 2031-03-31 F1 · derivative.exercise_date: Options were vested at the grant date. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 127,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0002012926-26-000004 · form4-02242026_080211.xml · derivative · entry 2 Blizard Jeffrey · CIK 0002012926 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,000 Underlying: Common Stock · 127,000 shares Expires 2036-02-20 F2 · derivative.exercise_date: The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 86,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002012926-26-000004 · form4-02242026_080211.xml · nonDerivative · entry 1 Blizard Jeffrey · CIK 0002012926 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,125 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 21:34 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,540 | $0.00 Strike: $29.84 | $0.00 |
DisclosureSEC source: 0002012926-26-000002 · form4-01062026_090110.xml · derivative · entry 1 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,540 Underlying: Common Stock · 1,540 shares Expires 2030-12-31 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 21:46 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,342 | $0.00 Strike: $37.48 | $0.00 |
DisclosureSEC source: 0002012926-25-000003 · form4-10022025_091052.xml · derivative · entry 1 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,342 Underlying: Common Stock · 1,342 shares Expires 2030-09-30 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:29 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,574 | $0.00 Strike: $32.86 | $0.00 |
DisclosureSEC source: 0001437749-25-022053 · rdgdoc.xml · derivative · entry 1 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,574 Underlying: Common Stock · 1,574 shares Expires 2030-06-30 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| June 02, 2025 Filed Jun 2, 2025 20:59 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 154,100 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001062993-25-010689 · form4.xml · derivative · entry 2 Blizard Jeffrey · CIK 0002012926 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,100 Underlying: Common Stock · 154,100 shares Expires 2035-06-02 F2 · derivative.exercise_date: The option vests 25% on June 2, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| June 02, 2025 Filed Jun 2, 2025 20:59 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 104,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010689 · form4.xml · nonDerivative · entry 1 Blizard Jeffrey · CIK 0002012926 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,125 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on June 2, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| May 28, 2025 Filed May 30, 2025 20:17 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 11,700 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001062993-25-010575 · form4.xml · derivative · entry 2 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,700 Underlying: Common Stock · 11,700 shares Expires 2035-05-28 F2 · derivative.exercise_date: The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| May 28, 2025 Filed May 30, 2025 20:17 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 7,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010575 · form4.xml · nonDerivative · entry 1 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,325 F1 · shares: These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 20:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,761 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001437749-25-011184 · rdgdoc.xml · derivative · entry 1 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,761 Underlying: Common Stock · 1,761 shares Expires 2030-04-03 F1 · derivative.exercise_date: Options were fully vested on the grant date. Read SEC document |
| December 31, 2024 Filed Mar 18, 2025 20:38 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,559 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001437749-25-008280 · rdgdoc.xml · derivative · entry 2 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,559 Underlying: Common Stock · 1,559 shares Expires 2029-12-31 F2 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| October 22, 2024 Filed Mar 18, 2025 20:38 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 41,333 | $0.00 Strike: $14.20 | $0.00 |
DisclosureSEC source: 0001437749-25-008280 · rdgdoc.xml · derivative · entry 1 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,333 Underlying: Common Stock · 41,333 shares Expires 2034-10-22 F1 · derivative.exercise_date: Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:55 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 9,300 | $0.00 Strike: $5.71 | $0.00 |
DisclosureSEC source: 0001062993-24-012081 · form4.xml · derivative · entry 2 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 9,300 shares Expires 2034-06-04 F2 · derivative.exercise_date: The option vests in 36 equal monthly installments on each monthly anniversary of June 4, 2024, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:55 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 6,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-012081 · form4.xml · nonDerivative · entry 1 Blizard Jeffrey · CIK 0002012926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,375 F1 · shares: These restricted stock units will vest in three equal annual installments beginning on June 4, 2025, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.